FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic Purpura
The genetically engineered protein product is safe, effective for the rare inherited blood clotting disorder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.